OXiGENE Announces Third Quarter 2008 Earnings Conference Call and Webcast WALTHAM, MA - October 30, 2008 -- OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2008 results on Wednesday, November 5, 2008. A conference call and webcast hosted by OXiGENE management will begin at 2:00 p.m. EDT (11:00 a.m. PDT). To listen to a live or an archived version of the audio webcast, please log on to the Company's website, www.oxigene.com. Under the "Investor Center" tab, select the link to "Presentations & Conference Calls." OXiGENE's earnings conference call can also be heard live by dialing (866) 564-7442 in the United States and Canada, and (719) 234-0008 for international callers, five minutes prior to the beginning of the call. A replay will be available starting at 5:00 p.m., EDT (2:00 p.m., PDT) on November 5, 2008 and ending at 5:00 p.m. EDT (2:00 p.m., PDT) on Wednesday, November 12, 2008. To access the replay, please dial (888) 203-1112 if calling from the United States or Canada, or (719) 457-0820 from international locations. Please refer to replay pass code 3419244. About OXiGENE OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The company's major focus is developing vascular disrupting agents (VDAs) that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients.
OXiGENE Announces Third Quarter 2008 Earnings Conference Call and Webcast
| Source: Oxigene, Inc.